A qualitative study to evaluate patients’, carers’ and doctors’ opinions on blood biomarker tests to monitor the treatment of oesophageal, gastric and colorectal cancers

Flinders Medical Centre0 sites120 target enrollmentStarted: January 24, 2022Last updated: February 5, 2024

Conditions

Trial Snapshot

No summary available.

•Participants, carers and clinicians who fit the following criteria will be invited into the study:
•1)be over 18 years of age and be willing to participate in a focus group either in person at the Flinders Centre for Innovation in Cancer (Bedford Park, South Australia), or be able to participate in group discussion via a web-based format e.g. Microsoft Teams or Zoom.
•2)have undergone treatment (within the previous 3 years) of stomach, oesophageal or bowel cancer, OR have supported someone who has a history of one of these cancers, OR work in a clinical role providing clinical care for patients with these cancers.

•Participants will be excluded if:
•1)They are in the palliative phase of their cancer;
•2)Have any underlying conditions (e.g., anxiety/depression) where discussing their diagnosis and treatment might exacerbate any symptoms.
•Participants, carers or clinicians will be excluded if:
•1)They have a perceived or actual conflict of interest relating to any blood biomarker tests.

Sponsor